Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization study

Chen Hu1, Eleni S Vasileiou1, Amber Salter2

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Abstract

Insights

Genetic susceptibility to multiple sclerosis (MS) is linked to specific depression symptoms like anhedonia and concentration issues. This study used Mendelian randomization to explore the causal link between MS and various depressive symptoms.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Depression is a common and varied condition in multiple sclerosis (MS).
  • MS may influence the risk of certain affective symptoms, or conversely, some symptoms might increase MS risk.

Purpose of the Study:

  • To investigate the causal relationship between distinct depressive symptoms and MS.
  • To determine the directionality of causality using two-sample Mendelian randomization (MR).

Main Methods:

  • Utilized genome-wide association study data for MS (n=115,776) and depressive symptoms (n=117,713).
  • Assessed nine depressive symptoms: anhedonia, altered appetite, concentration, depressed mood, fatigue, inadequacy, psychomotor changes, sleeping problems, and suicidality.
  • Employed two-sample MR with inverse-variance models and sensitivity analyses, adjusting for body mass index in multivariable-MR.

Main Results:

  • Found genetic liability to MS associated with anhedonia, concentration difficulty, and psychomotor changes.
  • Sensitivity analyses confirmed these associations.
  • No evidence of a causal relationship was found for any depressive symptom influencing MS risk.

Conclusions:

  • Genetic susceptibility to MS is specifically associated with anhedonia, concentration difficulties, and psychomotor changes.
  • These findings suggest a distinct depressive symptom phenotype in individuals with MS.

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
58
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
69
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
204